nivolumab,ipilimumab,cabozantinib,sunitinib
bms,pfizer
['rcc,(-irccs),(-srcc),(-urcc)', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', 'check,mate,9er', 'cabo ', 'nivo']
3 yr f/u of ph 3 checkmate 9er: nivo + cabo vs sun for 1l rx of arcc #gu23 nivo + cabo vs sun: itt mpfs: 16.6 vs 8.4 mo (hr 0.58, 95% ci 0.48 0.71) itt mos: 49.5 vs 35.5 mo (hr 0.70, 95% ci 0.56 0.87) orr: 55.7% vs 28.4% cr rate: 12.4% vs 
Uro Onc @GACancerCenter | Res PD & Ronald W. Lewis MD Chair of Uro Educ @mcg_urology | Digital Media Ed @EUplatinum | #mentalhealth research | @urotoday